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Act in such a way that you treat humanity, whether in your own
person or in the person of another, always at the same time as
an end and never simply as a means.
-Immanuel Kant, Grounding for the Metaphysics of Morals'
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1. IMMANUEL KANT, ETHICAL PHILOSOPHY 1, 36 (James W. Ellington trans., Hackett
Publ'g Co. 1983) (1785).
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The voluntary consent of the human subject is absolutely essen-
tial. This means that the person involved should have legal
capacity to give consent ....
-Nuremberg Code'
States Parties shall protect the child against all other forms of
exploitation [in addition to economic and sexual exploitation],
prejudicial to any aspects of the child's welfare.
-Convention on the Rights of the Child3
I. INTRODUCTION
On October 19, 2005, the United Nations Educational, Scientific,
and Cultural Organization (UNESCO) adopted an international declara-
tion of universal norms for bioethics as a possible model for a future
multinational treaty. This Universal Declaration on Bioethics and Hu-
man Rights (Declaration) is an important international expression of a
moral commitment to fundamental principles governing the development
and application of science and technology.' The Declaration is important
not only as a precursor to an international convention but also as a con-
tribution to the growing body of international, national, and regional
standards for scientific research involving human subjects.6 By providing
2. See 2 TRIALS OF WAR CRIMINALS BEFORE THE NUERENBERG [sic] MILITARY TRI-
BUNALS UNDER CONTROL COUNCIL LAW No. 10 181-82 (U.S. Gov't Printing Office 1950)
(containing full text of what has come to be known as the Nuremberg Code), available at
http://www.nihtraining.com/ohsrsite/guidelines/nuremberg.html (last visited Mar. 18, 2006).
3. Convention on the Rights of the Child art. 36, G.A. Res. 44/25, U.N. Doc.
A/RES/44/25 (Nov. 20, 1989), available at http://www.unhchr.ch/html/menu3/b/k2crc.htm.
4. U.N. Educ., Sci., & Cultural Org. [UNESCO], Universal Declaration on Bioethics
and Human Rights, General Conference of UNESCO, 33rd sess. (Oct. 19, 2005), available at
http://portal.unesco.org/shs/en/file download.php/46133e I f469 Ie4c6e57566763d474a4dBioet
hicsDeclarationEN.pdf [hereinafter Declaration]. See UNESCO, Report of the IBC on the
Possibility of Elaborating a Universal Instrument on Bioethics, U.N. Doc. SHS/EST/02/CIB-
9/5 (rev.3) (June 13, 2003), available at http://portal.unesco.org/shs/en/file-download.php/
3880b5df8e0530134614da8d65c39d6aFinrep_UIB-en.pdf [hereinafter Report of the IBC];
Intersections of Medical Ethics and International Human Rights Workshop (Austl. Sept. 2-4,
2004), at http://law.anu.edu.au/nissl/ethics.bg.pdf (recognizing the possibility of a subsequent
international convention on bioethics).
5. Ko'ichiro Matsuura, Dir.-Gen., UNESCO, Address at the twelfth session of the IBC,
Tokyo, Japan, U.N. Doc. DG/2005/201 (Dec. 15, 2005), at http://unesdoc.unesco.org/images/
0014/001428/142832e.pdf.
6. The Declaration could evolve into customary international law, which is binding on
states, as did the Universal Declaration of Human Rights. See T.A. Faunce, Will International
Human Rights Subsume Medical Ethics? Intersections in the UNESCO Universal Bioethics
Declaration, 31 J. MED. ETHICS 173-78 (2005).
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a "universal framework of principles and procedures to guide states in
the formulation of their legislation, policies or other instruments in the
field of bioethics," the Declaration could affect national laws and poli-
cies on bioethics, even though in its current form it does not bind states
to its norms.7 Policymakers in states around the world are already re-
sponding to the Declaration by considering ways in which to implement
its principles domestically. Just a few months after the Declaration's
signing, bioethics experts, professors, and national policymakers from 47
states met in Tokyo to discuss its impact and implementation.'
Potentially problematic aspects of the Declaration should continue to
receive immediate attention in the international discourse on bioethics.
One troublesome Declaration provision that this Note will address con-
cerns experimentation on human subjects, such as children, who are
incapable of giving consent. The Declaration should spark a reexamina-
tion at the international level of the historical and current norms
concerning experimentation on children. Any future binding treaty on
human experimentation should improve upon the Declaration by includ-
ing an outright ban of non-therapeutic research on children, while
allowing therapeutic research under certain conditions. International
standards should protect children from non-therapeutic research, which
offers them no direct health benefit. Parental consent, minimal risk limi-
tations, and ethics committee discretion are poor proxies for informed
consent, which children lack the legal capacity to give.
7. Declaration, supra note 4, art. 2(a).
8. List of Participants, twelfth session of the IBC, Tokyo, Japan, Dec. 15-17, 2005, at
http://portal.unesco.org/shs/en/file-download.php/4e6c6bce3e98ac ldc52bf92cb7433537Partic
ipants 12+IBC.pdf. The participants at this conference, the twelfth session of the UNESCO
IBC, came from thirty countries: Argentina, Australia, Canada, the Democratic Republic of
Congo, Estonia, France, Germany, Hungary, India, Israel, Italy, Jamaica, Japan, Jordan,
Lithuania, Mexico, Morocco, New Zealand, the Netherlands, Nigeria, Pakistan, the Philip-
pines, Portugal, Spain, Syria, Turkey, Uganda, Uruguay, Venezuela, and Vietnam. The
participants included research fellows, professors of medicine, philosophy and natural sci-
ences, chairpersons of national bioethics committees, and members of various ethics councils.
Id. Also participating were twelve guest speakers and twenty-five observers from member
states, permanent missions of observation, and national commissions for UNESCO (from the
Holy See, Angola, Argentina, Austria, Belgium, Brunei Darussalam, Colombia, France, Ger-
many, Iran, Kazakhstan, Kuwait, Mexico, Mongolia, the Philippines, the Republic of Korea.
Saudi Arabia, Thailand, the United States, and Zimbabwe). Id. Representatives from UN or-
ganizations and international intergovernmental and nongovernmental organizations
participated: the Food and Agriculture Organization of the United Nations (FAO), the United
Nations University, the International Centre for Genetic Engineering and Biotechnology
(ICGEB), the World Federation of Teachers' Unions (WFTU), the International Federation of
University Women (IFUW), the International Council of Jewish Women, and the Human Ge-
nome Organisation (HUGO). Id. About 128 professors, lawyers, scientists, and bioethics
experts from Japan, the host country, participated. Id. Finally, fourteen "other observers" were
present-academics from Australia, France, Hong Kong, Japan, Kuwait, Poland, the United
Kingdom, and the United States. Id.
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After describing the Declaration and its drafting history, this Note
will summarize several international, national, and regional guidelines
regarding children as research subjects. The Note then argues for a pro-
hibition of non-therapeutic research on children and concludes that
international human rights law offers the most appropriate basis for the
development of regulations on human experimentation.
II. THE DRAFTING OF UNESCO's UNIVERSAL DECLARATION ON
BIOETHICS AND HUMAN RIGHTS (2005)
The Declaration's origins can be traced back to October 2001, when
participants in the Round Table of Ministers of Science on "Bioethics:
International Implications" invited UNESCO to examine the possibility
of developing a universal instrument on bioethics, with UNESCO's Uni-
versal Declaration on the Human Genome and Human Rights as a
starting point.9
UNESCO is a specialized agency of the United Nations and was
"[flounded on the belief that there can be no peace without the intellec-
tual and moral solidarity of humankind."' From the 1980s to the late
1990s, critics frequently described UNESCO as the most "politicized" of
the UN specialized agencies." Recently, however, UNESCO has under-
gone a revitalization, partly because of consensus within the organization
with respect to its 1997 Universal Declaration on the Human Genome
and Human Rights.'
2
In 1993, UN member states gave UNESCO a mandate to work in the
area of bioethics." After the UN General Assembly endorsed UNESCO's
9. Report of the IBC, supra note 4, 2.
10. UNESCO Bioethics website, http://portal.unesco.org/shs/en/ev.php-URLID=
1372&URLDO=DOTOPIC&URLSECTION=201 .html.
11. The United States withdrew from UNESCO in 1984 and the United Kingdom in
1986, both countries complaining of extensive mismanagement, excessive budget growth and
increased politicization. Allyn L. Taylor, Globalization and Biotechnology: UNESCO and an
International Strategy to Advance Human Rights and Public Health, 25 AM. J.L. & MED. 479,
525 (1999). The United Kingdom rejoined UNESCO in 1997 and the United States in 2003.
Id. See also UNESCO Europe and North America website, http://portal.unesco.org/
geography/en/ev.php-URLID=2317&URLDO=DOTOPIC&URLSECTION=201 .html
(listing current European and North American members of UNESCO).
12. See Taylor, supra note 11, at 527; See also Noelle Lenoir, Comment, Universal
Declaration on the Human Genome and Human Rights: The First Legal and Ethical Frame-
work at the Global Level, 30 COLUM. HUM. RTS. L. REV. 537, 559 (1999).
13. UNESCO, First Intergovernmental Meeting of Experts Aimed at Finalizing a Draft
Declaration on Universal Norms on Bioethics, Explanatory Memorandum on the Elaboration
of the Preliminary Draft Declaration on Universal Norms on Bioethics, 3, U.N. Doc. SHS/
EST/05/CONF.203/4 (Feb. 21, 2005), available at http://unesdoc.unesco.org/images/
0013/001390/139024e.pdf [hereinafter Explanatory Memorandum].
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Universal Declaration on the Human Genome and Human Rights in
1998 and UNESCO's General Conference unanimously adopted the In-
ternational Declaration on Human Genetic Data in 2003, the General
Conference decided in October 2003 to begin work on a declaration con-
cerning universal norms in bioethics. 4 The UNESCO Director-General
entrusted the International Bioethics Committee (IBC) with initiating the
Declaration's drafting. 5 The IBC, created in 1993, is a body of 36 inde-
pendent experts, appointed by the Director-General of UNESCO, with
the mandate to "follow[] progress in the life sciences and its applications
in order to ensure respect for human dignity and freedom."'16 The
UNESCO General Conference selects the experts, who serve four-year
terms, by considering cultural diversity, balanced geographical represen-
tation, and the state nominations of qualified specialists in the life, social,
and human sciences. 17 The Director-General convenes the IBC at least
once a year.'8 The Declaration's elaboration also involved UN member
states, the UN itself, specialized UN agencies, intergovernmental organi-
zations such as the UN Inter-Agency Committee on Bioethics,
nongovernmental organizations, and national bodies and specialists.'9 The
drafters used international human rights law as the "essential framework"
and "starting point for the development of bioethical principles."20
The IBC engaged UNESCO member states and intergovernmental
and nongovernmental organizations during the nearly two years of draft-
ing and finalizing the Declaration. Beginning on January 20, 2004,
the IBC sent questionnaires to the 190 UNESCO member states to gather
their preliminary views on the scope and structure of the Declaration.2' By
June 2004, 67 member states had completed and returned questionnaires.22
14. Id. at U 4, 6. See Universal Declaration on the Human Genome and Human Rights,
UNESCO, 29th sess., 26th plen. mtg. (Nov. 11, 1997), available at http://portal.unesco.org/
en/ev.php-URLID= 13177&URL DO=-DOTOPIC&URLSECTION=201.html; International
Declaration on Human Genetic Data, UNESCO, 32d sess., 20th plen. mtg. (Oct. 16, 2003),
available at http://www.academy.ac.il/bioethics/english/documents/HumanGenetic_ Data.pdf.
15. Explanatory Memorandum, supra note 13, 6.




19. Explanatory Memorandum, supra note 13, 7.
20. Id. 11. A similar approach was taken in Resolution 2003/69 on Human Rights and
Bioethics of the United Nations Commission on Human Rights of 25 April 2003. Commission
on Human Rights Res. 2003/69, U.N. Doc. E/CN.4/2003/L. 1 l/Add.7 (April 25, 2003).
21. UNESCO, Different Stages in the Elaboration of the Universal Declaration on Bioethics
and Human Rights, at http://portal.unesco.org/shs/en/ev.php-URLID=3850&URL.DO=DO_
TOPIC&URL_- SECTION=201.htm (last visited Mar. 17, 2006) [hereinafter Different Stages].
22. Of the questionnaires returned, eleven were from Africa, eight from Asia and the
Pacific, ten from Arab states, 21 from Europe and North America, ten from Central and
Eastern Europe, six from Latin America and the Caribbean, and one from Permanent
Winter 2006]
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From April 27-29, 2004, the IBC held an Extraordinary Session to con-
duct hearings on the scope and structure of the Declaration, with
participation by approximately 200 representatives of intergovernmental
organizations, international nongovernmental organizations, and national
bioethics committees from 70 states.2 ' From April 30, 2004, through Janu-
ary 2005, the IBC drafters met six times at UNESCO Headquarters in
Paris and elaborated four draft outlines.24 During this period, the UN Inter-
Agency Committee on Bioethics and the Intergovernmental Bioethics
Committee (IGBC) each met twice to discuss the drafts.
The IGBC, created in 1998 under the auspices of the IBC, consists of
36 member states whose representatives meet at least once every two years
to examine the advice and recommendations of the IBC.26 The IGBC sub-
mits its opinions to the IBC and the Director-General of UNESCO for
transmission to member states, UNESCO's Executive Board, and
UNESCO's General Conference.27 UNESCO's General Conference elects
the 36 member states, which serve terms of four years, again considering
cultural diversity and balanced geographical representation. 28 Participation
and attendance at both IBC and IGBC sessions are open to UNESCO
member states, the UN, and other organizations of the UN system that
Observers. PowerPoint: Towards a Declaration on Universal Norms on Bioethics, Progress Report
(UNESCO Jan. 2005), at http://portal.unesco.org/shs/en/file.download.php/50523d754289e00
aad6dl699Od576e22Bioethics+Declaration(jan.2005).ppt [hereinafter Towards a Declaration].
23. The intergovernmental organizations were the Food and Agricultural Organization
of the United Nations (FAO), the World Intellectual Property Organization (WIPO), the
United Nations University (UNU), the Arab League Educational Cultural and Scientific Or-
ganization (ALECSO), the Organization for Economic Cooperation and Development
(OECD), the Council of Europe (CoE), and the European Commission. The international
nongovernmental organizations were the World Medical Association (WMA), the Human
Genome Organization (HUGO), the International Council for Science (ICSU), Disabled Peo-
ples' International (DPI), and the International Association of Bioethics (IAB). Id. The
national bioethics committees were those from Japan, New Zealand, Korea, Tunisia, Egypt,
France, Portugal, the United States, the United Kingdom, Crte d'Ivoire, the Republic of
Congo, Russian, Croatia, Mexico, and the Dominican Republic. Id.
24. Different Stages, supra note 21.
25. Id. The participants at the two meetings of the UN Inter-Agency Committee on
Bioethics were the FAO, UNESCO, UNU, WHO, WIPO, ALECSO, the European Commis-
sion, the CoE, the OECD, and the World Trade Organization (WTO). Towards a Declaration,
supra note 22.
26. Intergovernmental Bioethics Committee (IGBC) website, at http://portal.unesco.org/
shs/en/ev.php-URLID=-1878&URLDO=DOTOPIC&URLSECTION=201.html (last visited
Mar. 17, 2006). The member states of the IGBC are currently Cameroon, Canada, the People's
Republic of China, Costa Rica, Croatia, Cuba, the Czech Republic, Egypt, France, Germany,
India, Italy, Japan, Kazakhstan, Kenya, Mauritania, Mexico, Mozambique, the Netherlands,
Nigeria, Pakistan, Peru, Poland, Saudi Arabia, Senegal, Slovakia, Thailand, Tunisia, Uganda,
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have an agreement with UNESCO for reciprocal representation. 9 At the
invitation of the Director-General, non-member states with a permanent
observer mission at UNESCO and international governmental and non-
governmental organizations may also attend the meetings.0
From March 2004 to January 2005, the IBC drafters conducted na-
tional and regional consultations with experts." On August 23-24, 2004,
the IBC heard the views of representatives of religious and spiritual per-
spectives: Confucianism, Judaism, Hinduism, Islam, Buddhism, and
Catholicism.32 On October 19, 2004, UNESCO launched a written con-
sultation process that generated 75 contributions from interested
parties.33 On February 9, 2005, the IBC finalized and approved the Pre-
liminary Draft Declaration on Universal Norms on Bioethics. 4 On April
4-6, 2005, bioethics experts from around the globe met at the first inter-
governmental meeting of experts to finalize a draft of the Declaration.35
The next month, 55 member states met to "pave the way for consensus,"
reconciling their often conflicting views."' On June 20-24, 2005, the
second intergovernmental meeting of experts finalized the draft declara-
tion.37 Finally, on October 19, 2005, during its 33rd session, the General
Conference of UNESCO adopted by acclamation the Universal Declara-
tion on Bioethics and Human Rights. 8
From the inception of the drafting process, the IBC maintained that
the international instrument would not take the form of a treaty but
rather a nonbinding declaration expressing broad principles. 39 At the
same time, the IBC acknowledged that a declaration could serve as a
model for a binding treaty:
29. IBC website, supra note 16; IGBC website, supra note 26.
30. IBC website, supra note 16; IGBC website, supra note 26.
31. These consultations took place at the Hague, Hamedan, Vilnius, Ankara, Buenos
Aires, Seoul, Mexico City, Jakarta, Lisbon, and Moscow. Towards a Declaration, supra note
22.
32. Id.
33. These contributions included 31 from UNESCO member states and the Permanent
Observer, four from intergovernmental organizations, 14 from nongovernmental organiza-
tions, 14 from national bioethics committees, and 12 in a personal capacity. Id.
34. Different Stages, supra note 21.
35. UNESCO, Summary of the Informal Meeting with Permanent Delegations Organ-
ized by the Chairperson of the Intergovernmental Meeting of Experts (Category II) Aimed at
Finalizing a Draft Declaration on Universal Norms on Bioethics (May 17, 2005), at http://
portal.unesco.org/shs/en/file-download.php/95bb 1 eb8045b7e384d7e8e2d0bddba3Summary-
informal+meeting.en.pdf [hereinafter Informal Meeting].
36. Different Stages, supra note 21.
37. Id.
38. Id.
39. See, e.g., Report of the IBC, supra note 4, 39.
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The tradition of international instruments on human rights is that
treaties are preceded by declarations which contain guidelines
and an invitation to States to follow them. This was the case with
the two International Covenants of 1966 on Civil and Political
Rights and on Economic, Social and Cultural Rights, the Inter-
national United Nations Convention on the Elimination of All
Forms of Racial Discrimination (1965), the United Nations
Convention on the Elimination of All Forms of Discrimination
Against Women (1979) and the United Nations Convention on
the Rights of the Child (1989).40
The Declaration's provisions thus demand close scrutiny as they are re-
fined by international debate into a potential treaty.
III. THE SUBSTANCE OF UNESCO's UNIVERSAL DECLARATION ON
BIOETHICS AND HUMAN RIGHTS (2005)
The Declaration addresses its provisions to states, and its scope
comprises "ethical issues related to medicine, life sciences and associ-
ated technologies as applied to human beings.' Its aims are, inter alia,
to provide a framework of principles to guide states in the formulation of
bioethics legislation and policies; to promote respect for human dignity
and protect human rights; to foster pluralistic dialogue about bioethical
issues; to promote equitable access to medical, scientific, and techno-
logical developments (with particular attention to the needs of
developing states); and to underline the importance of biodiversity. 2 The
Declaration requires respect for the following principles: human dignity
and human rights; maximization of benefit and minimization of harm to
patients, research participants, and other affected individuals; autonomy
and individual responsibility; informed consent to medical intervention
and scientific research; special protection for persons without the capac-
ity to consent; human vulnerability and personal integrity; privacy and
confidentiality; equality, justice, and equity; non-discrimination and non-
stigmatization; cultural diversity and pluralism; solidarity and coopera-
tion; social responsibility and health; the sharing of benefits from
scientific research; protection of future generations; and protection of the
environment, the biosphere, and biodiversity."3 Article 27 is a general
exception provision that allows a state to limit these principles, by law,
"in the interest of public safety, for the investigation, detection and
40. Id. 143.
41. Declaration, supra note 4, art. 1.
42. Id. art. 2.
43. Id. arts. 3-17.
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prosecution of criminal offences, for the protection of public health or
for the protection of the rights and freedoms of others."4 Moreover, any
law that limits the principles of the Declaration must itself be consistent
with international human rights law.4 5 After sketching its principles in
broad terms, the Declaration provides guidelines for their application,
calling for transparent decisionmaking by ethics committees comprising
members of diverse backgrounds, among other procedural ideals. 6 The
Declaration also furnishes standards for transnational research prac-
tices .47
The Declaration relies on UNESCO, the IBC, the IGBC, and mem-
ber states to promote and disseminate its principles and procedures in
accordance with international human rights law.48 In honor of its com-
mitment, on December 15, 2005, UNESCO launched the Global Ethics
Observatory (GEO), comprising four databases of experts in ethics, eth-
ics institutions, ethics teaching programs, and ethics-related legislation
and guidelines.4 '9 The Declaration has already helped create a network of
experts and interested persons who will continue to refine its articles.
UNESCO hopes the Declaration will "inspire and stimulate further eth-
ics debates and their resolution within the member states in order to
expand the scope of this declaration and its usefulness."50
One area requiring further consideration encompasses the Declara-
tion's standards for experimentation on persons who are incapable of
giving informed consent-especially children. These provisions need
strengthening and clarification.
IV. CHILDREN AS RESEARCH SUBJECTS UNDER THE DECLARATION
The Declaration requires "prior, free, express and informed consent"
of the person who will serve as a subject of scientific research.5' The in-
formation should be "adequate" and "comprehensible," and the human
subject should be allowed to withdraw his consent at any time and for
44. Id. art. 27.
45. Id.
46. Id. arts. 18-20.
47. Id. art. 21.
48. Id. art. 25. See also Explanatory Memorandum, supra note 13, 115 ("The IBC
provides the only global expert forum for in-depth general, multidisciplinary bioethical reflec-
tion by exposing the issues at stake. It does not make binding rulings on specific bioethical
issues.").
49. UNESCO, Global Ethics Observatory (GEO) website, at http://portal.unesco.org/shs/
en/ev.php-URLID=6200&URLDO=-DOTOPIC&URLSECION=201.html (last visited Mar.
17, 2006).
50. Explanatory Memorandum, supra note 13, 29.
51. Declaration, supra note 4, art. 6(2).
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any reason.52 Some people, however, such as the mentally handicapped
and children, lack the legal capacity to consent to treatment or experi-
mentation. 3 This Note focuses on children.
The Declaration's protections for children should be analyzed ac-
cording to two categories of research: therapeutic and non-therapeutic. A
scientist performs therapeutic research when she approaches a child with
the mindset of a physician-that is, she conducts an experiment because
of its expected therapeutic effects on the child. This necessarily means
that the child suffers from the condition the researcher hopes to alleviate
and illuminate through her experiment. Gathering data on a new proce-
dure, medicine, or biochemical reaction is not the primary aim of
therapeutic research, although it might be a useful byproduct. The Decla-
ration allows therapeutic research on children so long as a legally-
defined surrogate gives proxy consent on behalf of the child in accor-
dance with domestic law and international human rights law.5
UNESCO's Explanatory Memorandum clarifies that "the domestic law
of Member States should provide for consent to be given by members of
the family, an official or court where the person concerned [is] incapable
of doing so.'' 5" Moreover, "the [child] should be involved to the greatest
extent possible in the decision-making process of consent, as well as that
of withdrawing consent."
56
In contrast, a U.S. state court has defined non-therapeutic research as
research that
generally utilizes subjects who are not known to have the condi-
tion [that] the objectives of the research are designed to address,
and/or is not designed to directly benefit the subjects utilized in
the research, but, rather, is designed to achieve beneficial results
for the public at large (or, under some circumstances, for
profit) 57
In a non-therapeutic experiment, the researcher does not approach
the child with the mindset of a physician but rather acts solely as a scien-
tist seeking to gather data for the benefit of others. The Declaration's
treatment of non-therapeutic research seems incoherent. First, the Decla-
ration categorically states that research involving a child should only be
52. Id. The Explanatory Memorandum explains that the doctrine of informed consent is
"largely a creation of court decisions" in which the right of individual self-determination has
been the basis. Explanatory Memorandum, supra note 13, 63.
53. See Markus Schott, Medical Research on Humans: Regulation in Switzerland, the
European Union, and the United States, 60 FOOD & DRUG L.J. 45, 73 (2005).
54. Declaration, supra note 4, art. 7.
55. Explanatory Memorandum, supra note 13, 169.
56. Declaration, supra note 4, art. 7(a).
57. Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807, 812 n.2 (Md. 2001).
[Vol. 27:629
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conducted for the child's "direct health benefit" (i.e., it permits only
therapeutic research). Then the Declaration allows experiments with no
potential direct health benefit (i.e., non-therapeutic research) "by way of
exception"-without defining the "exception.""8 The Declaration does
provide a few protective measures for children in the context of non-
therapeutic research: A surrogate must provide proxy consent on behalf
of the child, and children may serve as subjects of non-therapeutic re-
search only if the researcher exercises the "utmost restraint, exposing the
[child] only to a minimal risk and minimal burden."59 Additionally, non-
therapeutic research must be "compatible with the protection of the indi-
vidual's human rights," and "[r]efusal of such persons to take part in
research should be respected.'' 0
The second half of this Note argues that the Declaration should have
banned non-therapeutic research on children altogether; an experiment
exposing a child to even minimal risk should be prohibited if it offers no
direct therapeutic benefit. In this regard, however, the Declaration is not
inconsistent with most prior international and Council of Europe ap-
proaches to non-therapeutic research involving children.
V. INTERNATIONAL AND COUNCIL OF EUROPE STANDARDS
Legal protections for research subjects in the past century began
with the trial of 23 Nazi scientists for war crimes and crimes against
humanity at Nuremberg, Germany, immediately after the Second World
War.6' The trial judges, American attorneys appointed by the Military
Governor of the American Zone, promulgated their opinions as interna-
tional criminal law.62 Sixteen of the defendants were found guilty, and
seven were hanged.63 The Nuremberg judges employed a set of 10 stan-
dards for medical research, which have come to be known as the
Nuremberg Code.6 Of the 10 points of the Nuremberg Code, the abso-
lute requirement of informed consent receives the most treatment and the
first position:
58. Declaration, supra note 4, art. 7(b).
59. The Declaration does not define "minimal risk" or "minimal burden." Id.
60. Id.
61. The trial was known as United States v. Karl Brandt. Twenty were doctors, and all
but one of them held positions in the Third Reich. See PAUL M. McNEILL, THE ETHICS AND
POLITICS OF HUMAN EXPERIMENTATION 17, 22 (1993).
62. Id.
63. Id.
64. Nuremberg Code, supra note 2, at 181-82. See also JAY KATZ, EXPERIMENTATION
WITH HUMAN BEINGS: THE AUTHORITY OF THE INVESTIGATOR, SUBJECT, PROFESSIONS, AND
STATE IN THE HUMAN EXPERIMENTATION PROCESS 305-06 (1980).
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The voluntary consent of the human subject is absolutely essen-
tial. This means that the person involved should have legal
capacity to give consent; should be so situated as to be able to
exercise free power of choice, without the intervention of any
element of force, fraud, deceit, duress, over-reaching, or other
ulterior form of constraint or coercion; and should have suffi-
cient knowledge and comprehension of the elements of the
subject matter involved as to enable him to make an understand-
ing and enlightened decision.65
By requiring that the person involved have "legal capacity to give
consent," the Nuremberg Code effectively prohibits any research on
children, whether therapeutic or non-therapeutic, since they cannot give
legal consent. The Nuremberg Code requires that consent be voluntary,
competent, informed, and comprehending.6 Strongly interpreted, this
requirement bars surrogate consent; had it envisioned otherwise, the
Nuremberg Code would have provided distinct guidelines for research
on incapacitated adults and children.
By itself, the Nuremberg Code has no legally binding force, and no
international or domestic legislative body has ever adopted it.67 It is the
product of a military tribunal in response to a specific historical situa-
tion, and drafters of subsequent norms of medical research regarded its
absolute requirement of consent as undesirable.68 Departing from the
Nuremberg Code's strong consent principle, later international standards
imply that research involving children may be desirable if it is crucial to
developing cures for childhood ailments.
Western European physicians established the World Medical Asso-
ciation (WMA) in 1946 in direct response to the "medical war crimes"
perpetrated by Nazi scientists.69 In 1964, the WMA adopted the Helsinki
Declaration on Ethical Principles for Medical Research Involving Hu-
man Subjects,7° which deviates from the Nuremberg Code by allowing
experimentation on children provided a surrogate gives informed consent
65. Nuremberg Code, supra note 2, 1.
66. Id. For an exegesis of these requirements, see RUTH R. FADEN & TOM L.
BEAUCHAMP, A HISTORY AND THEORY OF INFORMED CONSENT 151, 155 (1986).
67. See Schott, supra note 53, at 47.
68. See id.
69. George J. Annas, The Nuremberg Code in U.S. Courts: Ethics versus Expediency, in
THE NAZI DOCTORS AND THE NUREMBERG CODE: HUMAN RIGHTS IN HUMAN EXPERIMENTA-
TION 201, 204 (George J. Annas & Michael A. Grodin eds., 1992).
70. World Medical Association [WMA], Declaration of Helsinki, Recommendations
Guiding Physicians in Biomedical Research Involving Human Subjects, 18th WMA Gen'l
Assembly, Helsinki, Fin., June 1964, available at http://www.wma.net/e/policy/b3.htm [here-
inafter Helsinki Declaration]. The Helsinki Declaration has been revised five times: in 1975,
1983, 1989, 1996 and 2000, and notes of clarification were added in 2002 and 2004. Id.
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and the child assents.7' "Assent" means simply any agreement to partici-
pate in an experiment with less than full understanding, while informed
consent requires full understanding. 2 Unlike the Nuremberg Code, the
Helsinki Declaration distinguishes between "medical care" and "medical
research" and permits medical research in conjunction with medical care
"only to the extent that the research is justified by its potential prophy-
lactic, diagnostic or therapeutic value. 73 In this respect, it is questionable
whether the Helsinki Declaration permits non-therapeutic research at all,
since it allows "medical research" only if the research has some thera-
peutic value. Like the Nuremberg Code, the Helsinki Declaration
requires the patient's informed consent for both medical care and medi-
cal research.74 Yet it departs from the Nuremberg Code by permitting, for
a legally incompetent minor, "informed consent from the legally author-
ized representative in accordance with applicable law" in lieu of the
child's consent.7' The Declaration also requires the researcher to obtain
the child's "assent," but only when the child "is able to give assent to
decisions about participation in research. '76 As a set of self-imposed pro-
fessional regulations, the Helsinki Declaration is not binding on
members of the World Medical Association.77 It has, however, influenced
71the formation of national legal requirements.
To give effect to the Helsinki Declaration, in 1993 the Council for
International Organizations of Medical Science (CIOMS) and the World
Health Organization (WHO) issued International Ethical Guidelines for
Biomedical Research Involving Human Subjects (CIOMS Guidelines). 79
The WHO and UNESCO jointly established the CIOMS in 1949 as a
71. Id.
72. See David N. Weisstub et al., Establishing the Boundaries of Ethically Permissible
Research with Vulnerable Populations, in RESEARCH ON HUMAN SUBJECTS: ETHICS, LAW AND
SOCIAL POLICY 355, 374 (David N. Weisstub ed., 1998).
73. Helsinki Declaration, supra note 70, 28.
74. Id. T 22.
75. Id. 24.
76. Id. 25.
77. Annas, supra note 69, at 205. Annas juxtaposes the reaction to the Helsinki Decla-
ration by Henry Beecher, who welcomed the Helsinki Declaration's "correction" of the
Nuremberg Code, to the reaction of Jay Katz, who admonished physicians not to place "too
much reliance on codes of ethics," which are "painfully vague." Id. at 206.
78. Schott, supra note 53, at 49. For example, the U.S. Food and Drug Administration's
policy on consent drew extensively from the Helsinki Declaration. See FADEN & BEAUCHAMP,
supra note 66, at 157.
79. INTERNATIONAL ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH INVOLVING
HUMAN SUBJECTS (Council for Int'l Organizations of Med. Sci., Geneva 2002), available at
http://www.cioms.ch/frame-guidelines nov_2002.htm [hereinafter INTERNATIONAL ETHICAL
GUIDELINES]. The Guidelines were revised in 2002. Id. For an analysis of the International
Ethical Guidelines, see Sev S. Fluss, The Regulation of Human Experimentation: Historical
and Contemporary Perspectives, in RESEARCH ON HUMAN SUBJECTS, supra note 72, at 222,
229.
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nongovernmental, nonprofit representative of the international biomedi-
cal community.80  Unlike the Helsinki Declaration, the CIOMS
Guidelines explicitly permit non-therapeutic research on children under
certain conditions.8' David Weisstub, Simon Verdun-Jones, and Janet
Walker summarize the conditions as follows: (1)researchers will not
involve children in experiments that might equally well be carried out
with adults; (2) the purpose of the research is to obtain knowledge rele-
vant to the health needs of children; (3) a parent or legal guardian of the
child has given proxy consent; (4) researchers have obtained the consent
of the child to the extent of the child's capabilities; (5) researchers must
respect the child's refusal to participate in research unless the research
provides the child with therapy for which there is no medically-
acceptable alternative; (6) the risk presented by an experiment not in-
tended to benefit the child is low and commensurate with the importance
of the experiment's results; and (7) experiments intended to provide
therapeutic benefit must be at least as likely to provide benefits to the
child as any available alternative.82 Like the Helsinki Declaration, the
CIOMS Guidelines are not binding.
The only binding treaty on bioethics is European, not international.
On April 4, 1997, the Committee of Ministers of the Council of Europe83
signed a binding treaty governing research on human subjects. 84 The
80. See Schott, supra note 53, at 5 1.
81. Id.
82. David N. Weisstub et al., Biomedical Experimentation with Children: Balancing the
Need for Protective Measures with the Need to Respect Children's Developing Ability to Make
Significant Life Decisions for Themselves, in RESEARCH ON HUMAN SUBJECTS: ETHICS, LAW
AND SOCIAL POLICY, supra note 72, at 380, 387 (citing INTERNATIONAL ETHICAL GUIDE-
LINES, supra note 79, at 20).
83. The Council of Europe (CoE) should not be confused with the Council of the Euro-
pean Union. See CoE website, http://www.coe.int; Council of Europe List of Member States,
at http://www.coe.int/T/E/Com/AboutCoe/Memberstates/default.asp. To become a member
of the European Union, a state must accede to two important treaties drawn up by the CoE: the
European Court of Human Rights and the European Committee for the Prevention of Torture.
See European Court of Human Rights, Historical Background, at http://europa.eu.int/comm/
externalrelations/coe/index.htm (discussing the relationship between the EU and CoE).
84. Convention for the Protection of Human Rights and Dignity of the Human Being
with Regard to the Application of Biology and Medicine: Convention on Human Rights and
Biomedicine, Apr. 4, 1997, E.T.S. No. 164 (CoE), available at http://conventions.coe.int/
Treaty/en/Treaties/Word/164.doc [hereinafter CoE Convention]. Three Additional Protocols to
the Convention have been signed, pertaining respectively to the cloning of human beings,
organ transplantation, and biomedical research. See Additional Protocol with Regard to the
Application of Biology and Medicine, on the Prohibition of Cloning Human Beings, Jan. 12,
1998, E.T.S. No. 186; Additional Protocol Concerning Transplantation of Organs and Tissues
of Human Origin, Jan. 24, 2002, ETS No. 186 (not yet entered into force); Additional Protocol
to the Convention on Human Rights and Biomedicine Concerning Biomedical Research,
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Convention for the Protection of Human Rights and Dignity of the Hu-
man Being with Regard to the Application of Biology and Medicine:
Convention on Human Rights and Biomedicine took effect on December
1, 1999, and has been ratified by 19 European states.85 Like the CIOMS
Guidelines and UNESCO's recent Declaration, the Council of Europe's
Convention allows, in exceptional cases, non-therapeutic research on
children:
Exceptionally ... where the research has not the potential to
produce results of direct benefit to the health of the person con-
cerned, such research may be authorised . .. if the research has
the aim of contributing, through significant improvement in the
scientific understanding of the individual's condition, disease or
disorder, to the ultimate attainment of results capable of confer-
ring benefit to the person concerned or to other persons in the
same age category or afflicted with the same disease or disorder
or having the same condition, [and] the research entails only
minimal risk and minimal burden for the individual concerned. 
6
The Convention also provides additional safeguards: The child's le-
gal representative must provide informed consent, it must be impossible
to perform the experiments on adults capable of giving consent, the child
must assent, and the research must entail only minimal risk and minimal
burden.87 These safeguards afford greater protection to children than the
UNESCO Declaration, which requires only that non-therapeutic research
on children be conducted "with the utmost restraint, exposing the [child]
only to a minimal risk and minimal burden" and "subject to the condi-
tions prescribed by law and compatible with the protection of the
individual's human rights."'
The same year the Council of Europe signed its Convention on Hu-
man Rights and Biomedicine, UNESCO adopted the Universal
Declaration on the Human Genome and Human Rights.8 At its adoption,
the Declaration on the Human Genome was the "most thorough global
initiative.., addressing the need to protect human rights with respect to
genetic advances."9 The Declaration on the Human Genome allows both
85. The countries that have ratified the Convention are Bulgaria, Croatia, Cyprus, the
Czech Republic, Denmark, Estonia, Georgia, Greece, Hungary, Iceland, Lithuania, Moldova,
Portugal, Romania, San Marino, Slovakia, Slovenia, Spain, and Turkey. Council of Europe web-
site, http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=164&CM=8&DF=23/l 1/
2005&CL=ENG.
86. CoE Convention, supra note 84, art. 17(2).
87. Id. art. 27.
88. Declaration, supra note 4, art. 7(b).
89. Universal Declaration on the Human Genome and Human Rights, supra note 14.
90. Taylor, supra note 11, at 509.
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therapeutic and non-therapeutic research involving children and their
genome. The Declaration also allows interventions that may alter a
child's genome after consultation with a third party who is "guided by
the person's best interest. ''9' Experimentation on such vulnerable persons
"may only be carried out for his or her direct health benefit" or if "[it] is
intended to contribute to the health benefit of other persons in the same
age category or with the same genetic condition."9 The Declaration has
received criticism for its alleged failure to adequately address human
rights considerations.93 Some critics argue that it elevates the protection
of the human genome over the protection of individual human rights.9'
No international, European, or U.S. law or standard has adopted the
Nuremberg Code's absolute requirement of informed consent and effec-
tive ban on any and all research involving children. Thus, UNESCO's
permission of non-therapeutic research involving children in its recent
Declaration on Bioethics and Human Rights is not out of line with the
other post-Nuremberg standards discussed above. This makes sense,
given that UNESCO's prior Declaration on the Human Genome pro-
vided some inspiration for the Declaration on Bioethics and Human
Rights and that UNESCO regards the Helsinki Declaration, the CIOMS
Guidelines, and the Council of Europe's Convention on Human Rights
and Biomedicine as identifying "acknowledged principles and standards
commonly adopted at the international level. 95 The Declaration on Bio-
ethics and Human Rights classifies non-therapeutic research on children
as an "exception" and requires the following: (1) surrogate consent in
accordance with domestic law; (2) the "utmost restraint" by the re-
searcher; (3) exposure of the child to no more than a minimal risk and
minimal burden; (4) compatibility with the protection of the child's hu-
man rights; and (5) respect for the child's refusal to take part in the
research (assent).
Even though the Declaration provides these safeguards for research
on children, the Nuremberg Code's overarching emphasis on informed
consent should not be forgotten. The Declaration on Bioethics and Hu-
man Rights presents an opportunity to revisit the principles underlying
informed consent and reevaluate whether researchers should ever subject
children to non-therapeutic experimentation.
91. Universal Declaration on the Human Genome and Human Rights, supra note 14,
art. 5.
92. Id.
93. See Taylor, supra note 11, at 510.
94. Id.
95. Explanatory Memorandum, supra note 13, 15. Although beyond the scope of this
Note, the U.S. federal regulations on research involving children are also consistent with the
Declaration's requirements of surrogate consent and minimal risk for research without any
benefit for the child subject. See 45 C.ER. §§ 46.404-407.
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VI. THE PROHIBITION OF NON-THERAPEUTIC
RESEARCH INVOLVING CHILDREN
Non-therapeutic research involving children should be prohibited for
two main reasons. First, individuals who lack the capacity to consent
should not be treated as instruments for the service of society. Second,
parental consent, "minimal risk" limitations, and ethics committee dis-
cretion do not provide adequate protections for children.
A. Children and Informed Consent
Psychiatrist Jay Katz wrote in his exhaustive anthology and case-
book, Experimentation with Human Beings (called "the most thorough
collection of materials on research ethics and law ever assembled be-
tween two covers"9), that "the concept of informed consent has been
accepted in case and commentary as a cardinal principle for judging the
propriety of research with human beings. 97 Informed consent derives
from the principle of autonomy, one of the four principles-along with
beneficence, nonmaleficence, and justice-from which contemporary
medical ethics has grown, according to Beauchamp and Childress in
Principles of Biomedical Ethics.9' The principle of autonomy is central
to both biomedicine and human rights law.99
Two conditions are essential in most theories of autonomy: (1) lib-
erty (lack of control by others) and (2) agency (capacity for independent
action).' °° Children are incapable of giving informed consent because
they lack complete autonomy."°" Because of their vulnerability, immatur-
ity, lack of knowledge, and physical weakness with respect to adults,
children require care from others and are therefore partially controlled
by others.'0 Children do not have the capacity for fully independent ac-
tion. This does not mean, however, that children lack all autonomy. They
are capable of making some decisions for themselves, and they will one
day become fully autonomous adults. The law should respect children's
nascent, potential autonomy.
Informed consent and autonomy are linked to notions of human dig-
nity and human rights. In its Explanatory Memorandum, UNESCO
96. FADEN & BEAUCHAMP, supra note 66, at 160.
97. KATZ, supra note 64, at 523.
98. See Intersections of Medical Ethics, supra note 4 (citing TOM L. BEAUCHAMP &
JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS 120 (4th ed., 1994)).
99. See Taylor, supra note 11, at 491 n.98 (citing Louis HENKIN, THE AGE OF RIGHTS 4
(1991)).
100. Id. (citing BEAUCHAMP & CHILDRESS, supra note 98, at 120-21).
101. See Schott, supra note 53, at 73.
102. See id.
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describes human dignity as follows: "Respect for human dignity flows
from the recognition that all persons have unconditional worth, each
having the capacity to determine his or her own moral destiny. Showing
disrespect to human dignity could lead to the instrumentalization of the
human person."'0 3 The Declaration's third article, on "Human Dignity
and Human Rights," declares that "[t]he interests and welfare of the in-
dividual should have priority over the sole interest of science or
society."'' 4 Thus, placing the interests of science or society over the in-
terests and welfare of a child turns the child into an instrument. Such
instrumentalization occurs in a non-therapeutic context because the
child, who is incapable of granting consent, receives no benefits from the
research; he merely gives of himself (sometimes quite literally) to sci-
ence or society.'5 This is exploitation, the use of someone for the benefit
of another.' °M The United Nations Convention on the Rights of the Child
of 1989 requires states parties to "protect the child against all ... forms
of exploitation prejudicial to any aspects of the child's welfare.' '0 7 What
is the utilization of children, at the mercy of a surrogate's consent, for
non-therapeutic research if not exploitation in violation of the Conven-
tion on the Rights of the Child?
B. Exploitation and Children
Historically, the "powerless and disadvantaged," including children,
have been most likely to suffer exploitation through unethical human
experimentation.' °8 Hippocrates is said to have performed an experiment
on a boy; while removing splinters from the boy's exposed cortex, he is
said to have scratched the surface of the cortex with his fingernail to ob-
serve the resulting movements on the other side of the boy's body.'"
Prisoners have been used throughout history for experimentation. "0 In
103. Explanatory Memorandum, supra note 13, 40.
104. Declaration, supra note 4, art. 3(2). This principle is derived from article 2 of the
Council of Europe Convention on Human Rights and Biomedicine, which states that "[t]he
interests and welfare of the human being shall prevail over the sole interest of society or sci-
ence." See Explanatory Memorandum, supra note 13, 41.
105. See FADEN & BEAUCHAMP, supra note 66, at 156 (explaining the definitions of
"therapeutic" and "non-therapeutic" as used in the Helsinki Declaration).
106. "Exploitation" means "[t]he act of taking advantage of something; esp., the act of
taking unjust advantage of another for one's own benefit." BLACK'S LAW DICTIONARY 475
(7th ed. abridged 2000).
107. Convention on the Rights of the Child, supra note 3, art. 36.
108. MCNEILL, supra note 61, at 17 (quoting R. Gillespie, Research on Human Subjects:
An Historical Overview, 1988 CONF. PROC: MONASH UNIV. CENTRE FOR Hum. BIOETHICS 3-
19).
109. Id.
110. Id. (noting that in ancient Egypt condemned prisoners were used for experimental
purposes).
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the late 1980s in New Zealand, the low social status of female subjects
was shown to be a factor in their selection by doctors for an experiment
in which treatment was withheld from women with carcinoma in situ of
the cervix."' The first mother of a "test-tube baby" was a factory worker
who was not even informed that she was the subject of an experiment.
"'
During the past 50 years, even after U.S. judges expounded the Nur-
emberg Code, non-therapeutic experiments have taken place in the
United States to the detriment of children's dignity. From 1956 to 1972,
researchers performed experiments on children at Willowbrook State
School, an institution for developmentally disabled children in Staten
Island, New York."3 Due to overcrowding and lack of toilet training, vir-
tually all susceptible children contracted a mild strain of hepatitis within
six to twelve months after moving to the school. Saul Krugman, Joan
Giles, and their team of researchers intentionally infected 750 to 800
healthy children at Willowbrook with strains of the hepatitis virus, ra-
tionalizing that the children would probably contract the virus within a
year at the school anyway. Krugman and Giles sought to study the incu-
bation period of hepatitis and test the effectiveness of gamma globulin in
treatment."4 Although the U.S. physician Henry Beecher called this ex-
periment "ethically dubious" in 1966, nothing was done to stop the
experiments, and the work continued. After all, the study had approval
from the New York State Department of Mental Hygiene, the New York
State Department of Mental Health, and the human experimentation
committees at the New York University School of Medicine and the
Willowbrook School."5 Criticism did not halt the experiments until after
1970, when Beecher questioned them again in his book, Research and
the Individual, ethicist Paul Ramsey lambasted them, and Dr. Stephen
Goldby published a critical letter in The Lancet."6 In his letter, Goldby
called the work "unjustifiable" and asked, "Is it right to perform an ex-
periment on a normal or mentally retarded child when no benefit can
result to the individual?"
' 7
In fact, Krugman and Giles justified their research by contending
that it offered therapeutic benefits to the subjects. They claimed the chil-
dren would receive excellent medical care, avoid exposure to other
111. Id.
112. Id. at 17-18.
113. FADEN & BEAUCHAMP, supra note 66, at 163.
114. ADIL E. SHAMOO & DAVID B. RESNIK, RESPONSIBLE CONDUCT OF RESEARCH 187
(2003).
115. Id. at 188.
116. FADEN & BEAUCHAMP, supra note 66, at 163.
117. Stephen Goldby, Correspondence, Experiments at the Willowbrook State School,
297 THE LANCET 749 (1971).
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diseases, and acquire immunity from stronger forms of hepatitis."8 Such
explanations futilely grasp at a therapeutic hook on which to hang ques-
tionable research-and do not justify intentionally infecting children
with hepatitis. Although Krugman and Giles obtained written informed
consent from the children's parents, some critics have suggested the par-
ents did not understand the nature of the study."9 Surrogate consent thus
did not prove much of a safeguard against this humiliating subjection of
healthy children to the hepatitis virus. The willingness of researchers to
use children in such a fashion, and the readiness of officials to offer sup-
port for the experiments, should caution against extending any latitude
for non-therapeutic research.
Even more egregious than the Willowbrook case were the Human
Radiation Experiments, which the U.S. government funded and con-
ducted on more than 4,000 unsuspecting individuals from 1944 to
1974.120 Although many studies did not significantly harm the subjects,
several exposed children to an increased risk of cancer over their life-
time, and the experiments as a whole directly or indirectly caused the
deaths of hundreds of adult subjects.' Yet the U.S. government rational-
ized the experiments by claiming they might help the United States win
or survive a nuclear war.122 In one of the studies, conducted from 1945 to
1947 at the Manhattan District Hospital in Oak Ridge, Tennessee, re-
searchers injected 18 patients with plutonium.'23 One subject was only
five years old.24 The patients did not give their informed consent, and the
researchers neither sought surrogate consent nor uttered the word "plu-
tonium" to the patients. '
In 1961, researchers from Harvard Medical School, Massachusetts
General Hospital, and Boston University School of Medicine adminis-
tered radioactive iodine to 70 children at the Wrentham State School, a
Massachusetts facility for developmentally disabled children. 26 The sci-
entists had received funding from the U.S. Public Health Service to test a
proposed countermeasure to nuclear fallout, even though children are
more susceptible than adults to harm from low levels of radiation. 27 The
118. SHAMOO & RESNIK, supra note 114, at 187.
119. Id. at 188.
120. Id. at 189.
121. Id.
122. Id.
123. McNEILL, supra note 61, at 33.
124. Id.
125. Id.
126. U.S. DEP'T OF ENERGY, ADVISORY COMM. ON HUMAN RADIATION EXPERIMENTS,
FINAL REPORT OF THE ADVISORY COMMITTEE ON HUMAN RADIATION EXPERIMENTS 196
(1996), available at http://www.eh.doe.gov/ohre/roadmap/achre/index.html.
127. Id.
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non-therapeutic research described by the Advisory Committee on Hu-
man Radiation Experiments also included experiments involving the use
of iodine 131 for the evaluation of thyroid function.'28 Little was known
at the time about the causal relationships between radiation exposure and
cancer and between iodine 131 and thyroid cancer, and the researchers
may have thought they were exposing the children to only minimal
risk. 129
D. "Minimal Risk" Limitations as Inadequate
Protections for Children
Leonard Glantz describes a 1997 research study that exemplifies the
"vagueness" of the concept of minimal risk when applied to research on
children." ° Scientists conducted a "minimal-risk" experiment on 34 im-
poverished African American and Hispanic boys from 7 to 11 years of
age to study the relationship of adverse-rearing conditions, aggression, and
serotonin in children.' The scientists selected the boys solely because
they were the younger brothers of "delinquents."'32 The subjects underwent
psychiatric assessments to detect oppositional defiant disorder, conduct
disorder, or attention-deficit hyperactivity disorder.' The investigators
ensured the boys were free of all medications for at least one month,
placed them on a low-monoamine diet for four days, and had the boys fast
for the night before the test (referred to as the "challenge").' On the day
of the "challenge," researchers inserted intravenous catheters into the boys,
and they remained in place for approximately five and a half hours. 33 The
researchers orally administered fenfluramine hydrochloride to the boys
and took blood samples every hour from the catheters. 36 The researchers
conducted the experiments "to replicate results that have suggested that
aggression in prepubertal children is positively correlated with central
serotonergic activity.
' ' 37
This study should not have been performed, as it offered the boys no
possible benefit and subjected them to discomfort and possible harm.
128. Id. at 204.
129. Id. at 212.
130. Leonard H. Glantz, Research with Children, 24 AM. J.L. & MED. 213, 238 (1998)
(citing Daniel S. Pine et al., Neuroendocrine Response to Fenfluramine Challenge in Boys:
Association with Aggressive Behavior and Adverse Rearing, 54 ARCHIVES GEN. PSYCHIATRY
839, 840 (1997)).
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The social dimensions of the experiment (the boys' status as minorities
and younger brothers of delinquents) and the probable incompleteness of
the parents' understanding highlight the boys' instrumentalization.
Moreover, the drug, fenfluramine hydrochloride, had previously been
documented to cause adverse reactions in adults.'38 Glantz asks, "Why
should a parent have the authority to submit a child to such nonbeneficial
procedures?" 9
It is unclear why the researchers in the experiment described above
identified the risk level to the boys as "minimal'" Definitions of "mini-
mal risk" pose problems themselves. U.S. federal regulations define
"minimal risk" as a level of risk where "the probability and magnitude of
harm or discomfort anticipated in the research are not greater in and of
themselves than those ordinarily encountered in daily life or during the
performance of routine physical or psychological examinations or
tests." 40 Glantz points out that many adolescents engage in sex without
condoms and many children ride bicycles without helmets, then ques-
tions whether research studies that randomize condom use in a group of
adolescents or randomize helmet use in bicycle-riding children would be
"minimal risk" studies-after all, such studies only expose the minor
subjects to risks occurring in everyday life.41 Glantz concludes that
"[g]iven the variability in how minimal risk can be applied.., a techni-
cal reading of the definition in the federal regulations would permit some
research that would present substantial risks to [some] children."'
4 2
E. Surrogate Parental Consent as Inadequate
Protection for Children
Unfortunately, because of ignorance, neglect, mistake, or some other
reason, parents cannot always be trusted to act in the best interests of
their child. In a 1953 experiment, a mother gave her surrogate consent
for scientists to study the influence of phenylalanine intake on her two-
year old daughter's phenylketonuria, a condition the doctors suspected
had caused her developmental disability.4 3 When the scientists instructed
the mother to give her daughter a special diet low in phenylalanine, the
mother reported that the girl's mental state improved within a few
138. Id.
139. Id.
140. 45 C.F.R. § 46.102(i).
141. Glantz, supra note 130, at 232.
142. Id. at 233.
143. KATZ, supra note 64, at 958-59 (citing Horst Bickel et al., Influence of Phenyla-
lanine Intake on Phenylketonuria, 262 THE LANCET 812-13 (1953)); see also M.H.
PAPPWORTH, HUMAN GUINEA PIGs 32-33 (1967) (citing the experiment as reason why non-
therapeutic research on children should be disallowed).
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months: "she learnt to crawl, to stand, and to climb on chairs; her eyes
became brighter; her hair grew darker; and she no longer banged her
head or cried continuously."'" Thus far, the doctors had been performing
therapeutic research. The scientists did not conclude the experiment at
the therapeutic result, however. Instead, they reintroduced phenylalanine
into the child's diet to determine whether the clinical improvement was
due to the diet and not to natural development. 4 5 They did this without
the mother's knowledge and noted:
A definite deterioration in the child's condition ensued, the
mother reporting with distress that her daughter had lost in a few
days all the ground gained in the previous ten months; that
within six hours of starting the fresh supply of "food" the child
had begun to cry and to bang her head as in the past, and within
twenty-four hours could no longer stand and could scarcely
crawl.'46
Then, even after she had learned of the deception and seen the dele-
terious effect of phenylalanine on her child, the mother agreed to allow
the doctors to repeat the same experiment at a hospital, where the girl's
biochemical reactions could be more frequently recorded. After observ-
ing the girl improve on a low-phenylalanine diet for a few days, the
scientists again increased her phenylalanine intake. Once again,
"[w]ithin twenty-four hours the patient became irritable and drowsy, lost
interest in her food and surroundings, developed facial eczema, and sali-
vated profusely. She also became ataxic and vomited repeatedly. By the
sixth day she could no longer stand or crawl.' ' 7 Fortunately, the child
"almost completely recovered" within three weeks after the researchers
discontinued the additional phenylalanine. Yet the researchers did not
know with certainty that the girl would recover at all. If the girl had not
recovered, how could the mother have justified, morally, her consent to
the second imposition of this phenylalanine diet?
Another problem with allowing surrogate consent for non-therapeutic
research on children is linked to the inequities in research itself. Studies
show that better educated and wealthier individuals are more likely to re-
fuse to consent to experimentation.' Conversely, in research on children,
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studies show that parents who consent to research on their children have
little education and are underrepresented in the professional and mana-
gerial occupations. 49 Such parents may not be well-equipped to provide
truly informed consent on behalf of their children in any case.
F. Institutional Review Boards as Inadequate
Protection for Children
In the United States, Institutional Review Boards, or IRBs, are re-
sponsible for approving medical research involving human subjects and
determining the guidelines for such research.5 Some commentators ar-
gue that IRBs tend to underestimate risk.' Reasons for this possibility
include the fact that IRB members may be researchers themselves and so
may be biased in favor of the value of research.5 2 Second, IRB members
work in a group to classify the risks of research, and empirical evidence
has shown that groups are more willing to take chances than the average
individual within the group.'53 Dale Moore, an IRB member, provides
telling insight into the mindset of a medical researcher:
One of my colleagues sometimes relates an argument she had
with an investigator during an IRB meeting. She insisted on the
disclosure of a particular risk and the investigator vehemently
resisted her demand. Finally, in great frustration, the investigator
exclaimed: "If I tell them what you want me to, then they won't
want to participate!" Her response: "That's precisely the
point!
,,54
Sometimes medical researchers lose sight of protecting their research
subjects in favor of conducting the research.
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G. Two U.S. State Court Cases Limiting Non-Therapeutic
Research Involving Children
In 1995, a New York state court limited the use of children and men-
tally disabled individuals as research subjects. In TD. v. New York State
Office of Mental Health, after the lower court observed that "we have
had deplorable instances of over-reaching medical research in this coun-
try,''1 55 the appellate court, affirming the lower court's decision, held that
a parent or guardian ... may not consent to have a child submit
to painful and/or potentially life-threatening research procedures
that hold no prospect of benefit for the child and that may have
the same result as a denial of necessary medical treatment....
We emphasize, however, that our holding is limited to non-
therapeutic greater than minimal risk experimentation.
5 6
The court did not prohibit all non-therapeutic research but only non-
therapeutic research posing greater than minimal risk.
In 2001, the Maryland Court of Appeals went even further than the
TD. court and held that a "parent, appropriate relative, or other applica-
ble surrogate, cannot consent to the participation of a child or other
person under legal disability in nontherapeutic research or studies in
which there is any risk of injury or damage to the health of the sub-
ject." 5 7 In response to the conduct of the Kennedy Krieger Institute
(KKI) and Johns Hopkins University (Hopkins), the court in Grimes v.
Kennedy Krieger Institute, Inc. followed the informed consent principles
of the Nuremberg Code as the "preferred standard for assessing the le-
gality of scientific research on human subjects."'58 In that case, the
Environmental Protection Agency paid $200,000 to KKI, affiliated with
Hopkins, to measure the amount of lead in the blood of healthy children
living in lead-contaminated housing.'59 The researchers performed the
study on children because they are particularly susceptible to lead poison-
ing, and they recruited families with small children to live in selected lead-
contaminated houses. ' 6° Although the parents gave their written surrogate
155. T.D. v. N.Y. State Office of Mental Health, 626 N.Y.S.2d 1015, 1016 (Sup. Ct.
1995), aff'd and modified 650 N.YS.2d 173 (App. Div. 1996), appeal dismissed 690 N.E.2d
1259 (N.Y 1997).
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157. Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807, 858 (Md. 2001) (emphasis
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30 J.L. MED. & ETHICS 38 (2002); William G. Kelly, Comment, Ericka and Myron: Canaries
in the Mines, 13 ALB. L.J. Sci. & TECH. 173 (2002).
159. Grimes, 782 A.2d at 819.
160. Id. at 812, 823.
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consent to the experiment, the court was troubled that financial incen-
tives, such as food coupons, may have driven the consent.16 ' The court
held that "children should not have been used for the purpose of measur-
ing how much lead they would accumulate in their blood while living in
partially abated houses to which they were recruited initially or encour-
aged to remain, because of the study."'
62
Grimes is controversial, both because commentators consider it
more restrictive than the federal regulations and because it assigns dif-
ferent levels of permissibility to therapeutic and non-therapeutic
research. 63 Nevertheless, cases such as Grimes and TD. show that sup-
port for a prohibition against non-therapeutic research involving children
is within the bounds of legal reality. The UNESCO Declaration should
serve as inspiration to reexamine the ethics of submitting children to ex-
perimentation that offers them no benefit.
VII. CONCLUSION
International human rights law is the appropriate context for ongoing
discussions regarding experimentation on children. UNESCO has con-
tended that "modern bioethics is indisputably grounded in the values
enshrined in the Universal Declaration of Human Rights and the human
rights treaties that have followed it."' Any exploitation or instrumentali-
zation of children is a denial of human rights and as such concerns the
entire international community; accordingly, the community should ad-
dress these violations through an international convention on bioethics.
The necessity for this international discussion is increasing, as more
biomedical experiments span several states and as tissue collections,
DNA samples, and genetic data involved in medical research flow across
national borders.' 65 The December 2005 IBC conference in Tokyo was a
propitious start to such discussion and highlighted informed consent as
an area in need of further elaboration.'6 Of particular relevance in future
dialogues will be different cultural perspectives on the role of the indi-
vidual in "consent" and the relationship between the individual and the
161. Id. at 844.
162. Id. at 848.
163. See Kopelman, supra note 158, at 41.
164. Explanatory Memorandum, supra note 13, 34.
165. Report of the IBC, supra note 4, 14.
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public interest. 67 Respect for cultural pluralism, however, should not
permit researchers to use children in scientific experiments with no di-
rect health benefit, particularly since, by the very nature of "experiment,"
no researcher can know the attendant risks with any certainty.
167. See, e.g., Tomoaki Tsuchida, UNESCO Declarations in the Field of Bioethics and
Cultural Diversity, in Abstracts or Texts, supra note 166; Michel Revel, UNESCO Universal
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into Account, in id.; Tadafumi Kato, Informed Consent: Current Status in Clinical and Re-
search Settings in Japan, in id.; Renzong Qiu, Cultural Diversity in Bioethics, in id.; Satoko
Tatsui, Bioethics and Japan, in id.; Leonardo De Castro, Providing an Asian Character to the
Globalization of Bioethics, in id.; S. Qasim Mehdi, Bioethical Concerns in a Muslim Coun-
try-Pakistan, in id.
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